Harvey Investment Co. LLC Sells 3,749 Shares of DENTSPLY SIRONA Inc (XRAY)
Harvey Investment Co. LLC decreased its stake in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 1.8% during the first quarter, Holdings Channel reports. The institutional investor owned 208,171 shares of the medical instruments supplier’s stock after selling 3,749 shares during the period. DENTSPLY SIRONA comprises 2.7% of Harvey Investment Co. LLC’s investment portfolio, making the stock its 13th largest position. Harvey Investment Co. LLC’s holdings in DENTSPLY SIRONA were worth $12,998,000 as of its most recent SEC filing.
A number of other large investors also recently made changes to their positions in XRAY. Capital One National Association increased its stake in shares of DENTSPLY SIRONA by 0.7% in the third quarter. Capital One National Association now owns 31,373 shares of the medical instruments supplier’s stock valued at $1,864,000 after buying an additional 222 shares in the last quarter. Nottingham Advisors Inc. bought a new stake in shares of DENTSPLY SIRONA during the third quarter valued at $447,000. World Asset Management Inc increased its stake in shares of DENTSPLY SIRONA by 1.1% in the third quarter. World Asset Management Inc now owns 23,252 shares of the medical instruments supplier’s stock valued at $1,382,000 after buying an additional 244 shares in the last quarter. DnB Asset Management AS increased its stake in shares of DENTSPLY SIRONA by 6.7% in the third quarter. DnB Asset Management AS now owns 145,004 shares of the medical instruments supplier’s stock valued at $8,618,000 after buying an additional 9,100 shares in the last quarter. Finally, Sumitomo Mitsui Trust Holdings Inc. increased its stake in shares of DENTSPLY SIRONA by 4.1% in the third quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 818,781 shares of the medical instruments supplier’s stock valued at $48,660,000 after buying an additional 32,445 shares in the last quarter. 94.32% of the stock is currently owned by institutional investors.
DENTSPLY SIRONA Inc (NASDAQ:XRAY) traded down 0.45% during midday trading on Tuesday, hitting $62.13. The stock had a trading volume of 948,068 shares. The stock has a 50 day moving average of $62.81 and a 200 day moving average of $59.83. The stock has a market cap of $14.27 billion, a price-to-earnings ratio of 32.03 and a beta of 1.21. DENTSPLY SIRONA Inc has a 12 month low of $55.00 and a 12 month high of $65.83.
DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Friday, February 17th. The medical instruments supplier reported $0.67 earnings per share for the quarter, beating analysts’ consensus estimates of $0.65 by $0.02. DENTSPLY SIRONA had a net margin of 11.15% and a return on equity of 8.04%. The firm earned $996.50 million during the quarter, compared to analysts’ expectations of $1.02 billion. During the same period in the previous year, the company earned $0.65 earnings per share. DENTSPLY SIRONA’s quarterly revenue was up 48.5% compared to the same quarter last year. Analysts expect that DENTSPLY SIRONA Inc will post $2.85 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Thursday, April 13th. Investors of record on Friday, March 31st were given a $0.0875 dividend. The ex-dividend date of this dividend was Wednesday, March 29th. This is a boost from DENTSPLY SIRONA’s previous quarterly dividend of $0.08. This represents a $0.35 dividend on an annualized basis and a yield of 0.56%. DENTSPLY SIRONA’s payout ratio is 15.98%.
Several brokerages have weighed in on XRAY. Zacks Investment Research raised DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research report on Thursday, March 30th. Barrington Research cut DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Tuesday, February 21st. Stifel Nicolaus upgraded DENTSPLY SIRONA from a “hold” rating to a “buy” rating and raised their target price for the company from $62.00 to $70.00 in a research report on Monday, February 13th. Finally, Jefferies Group LLC dropped their target price on DENTSPLY SIRONA from $70.00 to $68.00 and set a “buy” rating on the stock in a research report on Monday, January 23rd. Three investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. DENTSPLY SIRONA has an average rating of “Buy” and a consensus target price of $67.75.
In related news, insider Bret W. Wise sold 146,900 shares of the business’s stock in a transaction on Wednesday, March 1st. The shares were sold at an average price of $64.17, for a total value of $9,426,573.00. Following the completion of the sale, the insider now directly owns 142,121 shares of the company’s stock, valued at $9,119,904.57. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Arthur D. Kowaloff sold 27,213 shares of the business’s stock in a transaction on Friday, February 17th. The shares were sold at an average price of $62.00, for a total transaction of $1,687,206.00. Following the completion of the sale, the director now directly owns 55,692 shares of the company’s stock, valued at $3,452,904. The disclosure for this sale can be found here. Over the last three months, insiders sold 355,254 shares of company stock valued at $22,347,841. 2.20% of the stock is owned by corporate insiders.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).
Receive News & Ratings for DENTSPLY SIRONA Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc and related companies with MarketBeat.com's FREE daily email newsletter.